In the February edition of CAPsules, a featured article “Beyond the Prescription: The Role of Compounding Pharmacies in Safe, Effective Treatment,” indicated that, “At the time of this writing, the Food and Drug Administration (FDA) delayed enforcement of its regulations until February 18, 2025, for state-licensed pharmacists and physicians compounding, and until March 19, 2025, for outsourcing facilities.”
The FDA announced after the February edition CAPsules was circulated that these dates have now been extended to April 22, 2025, and May 22, 2025, respectively.
To view the original article, please click here.